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PRESENTATION OF CASE: Authors present a case of a 55 year old patient with Type 1 neuroﬁbromatosis
(NF1) and a very large right thigh plexiform neuroﬁbroma. The patient had increasing difﬁculty with
mobilization due to this enlarging bulky mass. Preoperative embolization reduced the bleeding risk at
surgeryallowing successful gross resectionof themassbyamultidisciplinary surgical team. Limb function
was restored to normal.
DISCUSSION: Massive plexiform neuroﬁbromatosis is a rare expression of von Recklinghausen’s disease
or NF1. These large masses result in severe disﬁgurement and signiﬁcant functional disability. They are
extremely vascular and there is potential for malignant transformation.
CONCLUSION: These massive tumors require complex preoperative, intraoperative and postoperative
management strategies with involvement from a multidisplinary team. We discuss the challenges of
surgical intervention and to discuss the current literature.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Plexiform neuroﬁbromas are most commonly seen on the face
and neck [1]. Cases of lower extremity plexiform neuroﬁbromas
are seen less frequently and in addition are extremely vascular.
As a result, one single management option for plexiform neu-
roﬁbroma has not been established. Surgery is often delayed due
to fear of massive bleeding and signiﬁcant disﬁgurement and
debilitation occurs. The purpose of this report is to discuss a
case of a large plexiform neuroﬁbroma and review the current
literature.
2. Case report
A 55-year-old woman with NF1 was referred to our institu-
tion to evaluate a very large right thigh plexiform neuroﬁbroma
measuring approximately 40 pounds (Fig. 1). The lesion was affect-
ing the patient’s ability to walk and causing her a great deal of
discomfort. On examination, the patient had multiple café-au-
lait patches, axillary and inguinal freckling and multiple small
neuroﬁbroma nodules varying in size from 0.5 to 3 cm scattered
Abbreviations: (NF1), Type 1 neuroﬁbromatosis; (MRI), Magnetic resonance
imaging.
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over her entire body. The patient was diagnosed with neuroﬁ-
bromatosis at a young age. The patient’s family history was
signiﬁcant in that both her mother and son were diagnosed
with neuroﬁbromatosis. The patient also had a remote history of
an attempted resection, which was abandoned due to massive
bleeding.
The patient was mobilizing independently at home, albeit with
increasing difﬁculty due to the cumbersome mass. Imaging was
orderedand themagnetic resonance imaging (MRI) revealedamass
involving the entire anterior thigh thatwas extremely vascular. The
imaging was consistent with the diagnosis of peripheral neuroﬁ-
bromatosis and demonstrated enlarged and tortuous major vessels
(Fig. 2AandB).Abiopsyof the right thighareaconﬁrmedadiagnosis
of plexiform neuroﬁbroma.
A multidisciplinary team of vascular and orthopedic surgeons
received her care and felt a resection was feasible following pre-
operative embolization (Figs. 2–4). At operation the tumor was
dissected off the underlying quadriceps muscle and removed as
a single en-bloc mass. Following the tumor removal primary skin
closure was achieved. The patient recovered in hospital for 4
days and then was discharged home. The gross specimen mea-
sured 64 cm×35.5 cm×20 cm. Pathological examination revealed
a plexiform and diffuse neuroﬁbroma with foci of atypia. There
were areas of embolization with infarction but no malignant trans-
formation. At follow up the wound healed well and resulted in
a normal caliber and functioning limb (Fig. 5). Written informed
consent was obtained from the patient for publication of this case
report and accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this journal on
request
http://dx.doi.org/10.1016/j.ijscr.2015.01.015
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Large right thigh plexiform neuroﬁbroma.
3. Discussion
Neuroﬁbramatosis appears in two different neurocutaneous
autosomal dominant genetic forms. Neuroﬁbromatosis types 1 and
2 affect nerve cell tissue development and growth [1]. NF1, also
known as von Recklinghausen’s disease is the most common type
of Neuroﬁbramatosis (Table 1). Plexiform neuroﬁbromas occur in
26.7% of patients with NF1 [2]. Plexiform neuroﬁbromas present
at, or within the ﬁrst 2–5 years of life. Key characteristics include
hyperpigmentation, thickening of the skin and hair excess [3].
There are two types of plexiform neuroﬁbromas, nodular and dif-
fuse. Adiffuseplexiformneuroﬁbroma, also knownas elephantiasis
neuroﬁbromatosis, is characterized by an overgrowth of epidermal
Table 1
To diagnose NF1, two of the following clinical features must be present [6].
• Six or more café-au-lait macules >5mm in diameter in prepubertal
and >15mm in diameter in post pubertal individuals; for each
lesion, the longest diameter is measured
• Two or more neuroﬁbromas of any type of one plexiform
neuroﬁbroma
• Freckling of the axillary or inguinal regions
• Optic glioma
• Two or more Lisch nodules (iris hamartomas)
• A distinctive bony lesion such as sphenoid dysplasia or thinning of
the long bone cortex with or without pseudoarthrosis
• A ﬁrst-degree relative (parent, sibling, or offspring) with NF1 based
upon the above criteria
and subcutaneous tissue associatedwith awrinkled and pendulous
appearance [4]. It is mostly considered a benign tumor condition;
however malignant transformation has been reported in 2 percent
of patients with NF1 (or 4.2% or those 21 years of age or older)
[5].
The natural history of a plexiform neuroﬁbroma varies, as
some lesions remainasymptomatic superﬁcial lesions,while others
progress into large invasive disﬁguring lesions as seen in our case
[6]. Tumorprogression is a seriousproblem for patientswith aplex-
iform neuroﬁbroma due to the debilitating nature of the disease
to a patient’s function and potential for malignant transformation.
Child and adult patients with tumors that cannot be completely
removed are at particular risk.
In order to investigate the neuroﬁbroma MRI and computed
tomography are used to determine the site and the expansion
of the plexiform neuroﬁbroma. Unfortunately, however, these
imaging modalities are not reliable in deciphering between a
plexiformneuroﬁbromaand those that haveprogressed intomalig-
nant peripheral nerve sheath tumors (MPNST) [16]. MPSNT usually
arise fromplexiformneuroﬁbroma, they tend tometastasizewidely
andusually have apoor prognosis.More recentlywith the advent of
positron emission tomography with the glucose analogue ﬂuorine-
18-ﬂuorodeoxyglucose the diagnosis can be determined. It is a
functional imaging technique which allows the visualization and
quantiﬁcation of glucose metabolism and reﬂects the increase in
metabolism in malignant tumors [17]. However, the gold standard
in identifying malignant transformation within a plexiform neu-
roﬁbroma is histology. Unfortunately histology requires complete
excision,which is not always possible. If a core biopsy is performed,
the malignant change may be missed within a large heterogeneous
tumor [18].
Surgical intervention is therefore an important therapeutic
and diagnostic option, which has two goals: to provide histo-
Fig. 2. MRI scan demonstrating markedly enlarged arteries going to the lesion with supply going from the profunda and tortuous superﬁcial femoral arteries (A+B). Pre
embolization peripheral angiogram demonstrating large collaterals supplying the tumor from superﬁcial femoral artery (C).
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Fig. 3. Pre (A) and Post (B) embolization peripheral angiogram demonstrating successful embolization of the vascular tumor in the right thigh using PVA particles.
logical diagnosis, to restore function and cutaneous appearance.
If surgical management is used, the lesion’s vascularity and its
abnormal propensity to bleed must be recognized. Some have
even compared plexiform neuroﬁbroma lesions to angiomas as
well as highlighted the friable nature of the lesion’s vessels [7].
For this reason it has been recommended to use pre-operative
angiography and embolization prior to surgery as was performed
in our case [8]. In our case we used polyvinyl alcohol (PVA)
particles which have been proven to be safe and effective in
many clinical scenarios for decades. To ensure optimal out-
comes a multidisciplinary surgical team is advantageous. There
are very few case reports that discuss plexiform neuroﬁbroma
resections in the lower limbs [9–13] and our case adds to the
evidence for preoperative embolization to ensure safe resection.
There are also reports in the literature of a resection of a plexi-
form neuroﬁbroma inﬁltrating the middle and lower parts of the
patient’s face [14] and reports of spinal neuroﬁbromas removal
[15].
Fig. 4. The large thigh plexiform neuroﬁbroma following embolization causing
some localized skin necrosis.
Fig. 5. Post-operative result.
4. Conclusion
In this case the patient had a massive lower limb plexiform
neuroﬁbroma affecting her quality of life. The surgical resection
was considered complicated because the plexiform neuroﬁbroma
involved the entire anterior thigh and was extremely vascular.
Preoperative embolization reduced the bleeding risk at surgery
allowing successful gross resection of the mass by a multidisci-
plinary surgical team. This strategy is essential for safe removal of
these very vascular tumors. Limb function was restored to normal
and the patient was extremely satisﬁed with the result.
Key learning points
• Massive plexiform neuroﬁbromatosis is a rare expression of von
Recklinghausen’s disease or Type 1 neuroﬁbromatosis.
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• Tumor progression is a serious problem for patients with a plexi-
formneuroﬁbromadue to the debilitating nature of the disease to
a patient’s function and potential for malignant transformation.
• Treatment has two goals, to restore function and to restore cuta-
neous appearance. This demands a multidisciplinary approach
with preoperative embolization central to minimize peri-
operative hemorrhage.
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